drugset / Trial / NCT00693706
Safety and Immune Response Study of GSK Biologicals' Influenza Virus Vaccine 1388442A Compared With Fluarix
RandomizedParallel-groupTriple-blindPrevention
Summary
The purpose of the study is to compare the safety of \& immune response to a single dose of GSK Biologicals' cell-culture based influenza vaccine 138842A with that of a US licensed, egg-based trivalent influenza vaccine \[Fluarix\] in healthy adults.
Timeline
- Start
- 2008-06-02
- Primary completion
- 2009-03-01
- Completion
- 2009-03-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GSK 138842A | Unknown | — | Intramuscular |
| Comparator | Influenza Virus Vaccine | Vaccine | — | Intramuscular |